221 related articles for article (PubMed ID: 25774712)
1. Incidence of nodal metastasis and isolated aortic metastases in patients with surgically staged endometrioid endometrial cancer.
Sautua RR; Goiri K; Calle MA; Marin IJ; Artola AL
Int J Gynecol Cancer; 2015 Jun; 25(5):875-8. PubMed ID: 25774712
[TBL] [Abstract][Full Text] [Related]
2. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
[TBL] [Abstract][Full Text] [Related]
3. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N
Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094
[TBL] [Abstract][Full Text] [Related]
4. Prediction of para-aortic spread by gross pelvic lymph node findings in patients with endometrial carcinoma.
Luomaranta A; Lohi J; Bützow R; Leminen A; Loukovaara M
Int J Gynecol Cancer; 2014 May; 24(4):697-702. PubMed ID: 24662132
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment.
Cosgrove CM; Cohn DE; Rhoades J; Felix AS
Gynecol Oncol; 2019 Jun; 153(3):505-510. PubMed ID: 30935714
[TBL] [Abstract][Full Text] [Related]
6. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Metastatic Regional Lymph Node Locations and Predictors of Para-aortic Lymph Node Involvement in Endometrial Cancer Patients at Risk for Lymphatic Dissemination.
Altay A; Toptas T; Dogan S; Simsek T; Pestereli E
Int J Gynecol Cancer; 2015 May; 25(4):657-64. PubMed ID: 25647255
[TBL] [Abstract][Full Text] [Related]
8. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging.
Mariani A; Dowdy SC; Cliby WA; Gostout BS; Jones MB; Wilson TO; Podratz KC
Gynecol Oncol; 2008 Apr; 109(1):11-8. PubMed ID: 18304622
[TBL] [Abstract][Full Text] [Related]
9. Should all endometrioid uterine cancer patients undergo systemic lymphadenectomy?
Wang ZQ; Wang JL; Shen DH; Li XP; Wei LH
Eur J Surg Oncol; 2013 Apr; 39(4):344-9. PubMed ID: 23333067
[TBL] [Abstract][Full Text] [Related]
10. The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes.
Abu-Rustum NR; Gomez JD; Alektiar KM; Soslow RA; Hensley ML; Leitao MM; Gardner GJ; Sonoda Y; Chi DS; Barakat RR
Gynecol Oncol; 2009 Nov; 115(2):236-8. PubMed ID: 19666190
[TBL] [Abstract][Full Text] [Related]
11. Contemporary analysis of pelvic and para-aortic metastasis in endometrial cancer using the SEER registry.
Katsoulakis E; Mattes MD; Rineer JM; Nabhani T; Mourad WF; Choi K; Schreiber D
Int J Gynaecol Obstet; 2014 Dec; 127(3):293-6. PubMed ID: 25194213
[TBL] [Abstract][Full Text] [Related]
12. Distribution of lymph node metastasis sites in endometrial cancer undergoing systematic pelvic and para-aortic lymphadenectomy: a proposal of optimal lymphadenectomy for future clinical trials.
Odagiri T; Watari H; Kato T; Mitamura T; Hosaka M; Sudo S; Takeda M; Kobayashi N; Dong P; Todo Y; Kudo M; Sakuragi N
Ann Surg Oncol; 2014 Aug; 21(8):2755-61. PubMed ID: 24705578
[TBL] [Abstract][Full Text] [Related]
13. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion.
Zahl Eriksson AG; Ducie J; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Abu-Rustum NR; Mariani A; Leitao MM
Gynecol Oncol; 2016 Mar; 140(3):394-9. PubMed ID: 26747778
[TBL] [Abstract][Full Text] [Related]
14. Relevance of pelvic and para-aortic node metastases in early-stage ovarian cancer.
Bachmann C; Krämer B; Brucker SY; Stäbler A; Fend F; Wallwiener D; Grischke EM; Rothmund R
Anticancer Res; 2014 Nov; 34(11):6735-8. PubMed ID: 25368283
[TBL] [Abstract][Full Text] [Related]
15. Comparison of lymphedema incidence between 2 lymphadenectomy techniques in patients with uterine cancer undergoing robotic staging.
Menderes G; Azodi M; Schwartz P; Silasi DA
Int J Gynecol Cancer; 2015 Jan; 25(1):160-5. PubMed ID: 25386859
[TBL] [Abstract][Full Text] [Related]
16. Can we omit para-aorta lymph node dissection in endometrial cancer?
Tanaka H; Sato H; Miura H; Sato N; Fujimoto T; Konishi Y; Takahashi O; Tanaka T
Jpn J Clin Oncol; 2006 Sep; 36(9):578-81. PubMed ID: 16870694
[TBL] [Abstract][Full Text] [Related]
17. To what extent should para-aortic lymphadenectomy be carried out for surgically staged endometrial cancer?
Dogan NU; Gungor T; Karsli F; Ozgu E; Besli M
Int J Gynecol Cancer; 2012 May; 22(4):607-10. PubMed ID: 22546819
[TBL] [Abstract][Full Text] [Related]
18. Role of adjuvant therapy in stage IIIC2 endometrial cancer.
Bogani G; Cappuccio S; Casarin J; Narasimhulu DMM; Cilby WA; Glaser GE; Weaver AL; McGree ME; Keeney GL; Weroha J; Petersen IA; Mariani A
Int J Gynecol Cancer; 2020 Aug; 30(8):1169-1176. PubMed ID: 32646864
[TBL] [Abstract][Full Text] [Related]
19. Systematic para-aortic and pelvic lymphadenectomy in early stage epithelial ovarian cancer: a prospective study.
Ditto A; Martinelli F; Reato C; Kusamura S; Solima E; Fontanelli R; Haeusler E; Raspagliesi F
Ann Surg Oncol; 2012 Nov; 19(12):3849-55. PubMed ID: 22707110
[TBL] [Abstract][Full Text] [Related]
20. A retrospective analysis of the diameter of metastatic lymph nodes in apparently early stage endometrial cancer.
Boran N; Akdag D; Halici F; Tulunay G; Turan T; Bozok S; Erdogan Z; Kose MF
Tumori; 2008; 94(5):681-5. PubMed ID: 19112940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]